Media release
From:
Attachments
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Research
Wiley-Blackwell, Web page
Please link to the article in online versions of your report (the URL will go live after the embargo ends).
Journal/
conference: Drug and Alcohol Review
conference: Drug and Alcohol Review
Research:Paper
Organisation/s:
The University of Sydney, La Trobe University, University of Otago
Funder:
PH has received funding from the Lambert Cannabis
Initiative at the University of Sydney to undertake clinical
trials of cannabinoid treatment for alcohol withdrawal
syndrome. PH has served on industry advisory
boards for Indivior, AbbVie and Gilead and has been
an investigator on clinical trials supported by
Camurus. He has also served on an International Advisory
Board for Lundbeck in relation to nalmefene. All
other authors have nothing to declare. The authors
declare that the research was conducted in the absence
of any commercial or financial relationships that could
be construed as a potential conflict of interest.